Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Entresto® Sprinkle (sacubitril/valsartan) – New formulation approval

April 12, 2024 - The FDA approved Novartis’ Entresto Sprinkle (sacubitril/valsartan), a new oral pellets within capsule formulation of Entresto.

Download PDF

Rx navigation